AL

Alma Yesodot Ltd.

KVSR | TA

Overview

Corporate Details

ISIN(s):
IL0011731457
LEI:
Country:
Israel
Address:
HaBarzel 3, 6971005 Tel Aviv - Jaffa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kvasir focuses on developing innovative medical devices and diagnostic technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Alma Yesodot Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-24 17:08
Regulatory News Service
Opening of Trading on April 27 2025-ALMA YESODOT B1
Hebrew (modern) 118.8 KB
2025-04-23 11:59
Regulatory News Service
Identifying Details of New Security-ALMA YESODOT B1
Hebrew (modern) 87.5 KB
2024-11-05 15:46
Regulatory News Service
Changes in the company's name and security, effective as of November 7, 2024
Hebrew (modern) 108.5 KB
2024-10-29 18:37
Regulatory News Service
The sector classification of the company will be changed, as of October 31, 202…
Hebrew (modern) 121.3 KB
2024-10-29 17:20
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2023-05-22 23:20
Report Publication Announcement
Frost and Sullivan is terminating coverage , following the completion of its co…
Hebrew (modern) 174.5 KB
2023-05-22 23:20
Pre-Annual General Meeting Information
Frost and Sullivan is terminating coverage , following the completion of its co…
Russian 46.0 KB
2023-03-23 21:00
Investor Presentation
Analysis update following financial report- price target is updated to NIS 22.7
English 1.2 MB
2023-03-23 21:00
Legal Proceedings Report
Analysis update following financial report- price target is updated to NIS 22.7
Russian 71.0 KB
2022-12-11 20:40
Investor Presentation
Analysis update following financial report- price target is updated to NIS 32.9…
English 1.2 MB
2022-12-11 20:40
Business and Financial Review
Analysis update following financial report- price target is updated to NIS 32.9…
Russian 67.3 KB
2022-08-30 20:47
Investor Presentation
Analysis update report ,target price is at 47.6NIS
English 1.2 MB
2022-08-30 20:47
Business and Financial Review
Analysis update report ,target price is at 47.6NIS
Russian 63.9 KB
2022-08-18 16:58
Investor Presentation
Presentation
English 3.0 MB
2022-08-18 16:58
Pre-Annual General Meeting Information
Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Alma Yesodot Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alma Yesodot Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GC CELL CORPORATION Logo
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
South Korea 144510
GemVax & KAEL Co.,Ltd. Logo
Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.
South Korea 082270
Gencurix Inc. Logo
Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.
South Korea 229000
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.
South Korea 109820
GeneOne Life Science, Inc. Logo
Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.
South Korea 011000
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark GMAB
GENOLUTION INC. Logo
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea 225220

Talk to a Data Expert

Have a question? We'll get back to you promptly.